We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
-14.8%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$13.1B
AUM Growth
-$2.86B
Cap. Flow
-$262M
Cap. Flow %
-2%
Top 10 Hldgs %
37.9%
Holding
1,479
New
56
Increased
646
Reduced
399
Closed
58

Sector Composition

Rank Sector Weight
1 Real Estate 60.75%
2 Technology 8.8%
3 Healthcare 4.18%
4 Consumer Discretionary 3.61%
5 Financials 3.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SAFE
1151
Safehold
SAFE
$1.2B
$4K ﹤0.01%
+59
New +$4.97K
SANA icon
1152
Sana Biotechnology
SANA
$907M
$4K ﹤0.01%
551
KDNY
1153
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$4K ﹤0.01%
230
+77
+50% +$1.21K
ISEE
1154
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$4K ﹤0.01%
434
+78
+22% +$979
BLU
1155
DELISTED
BELLUS Health Inc.
BLU
$4K ﹤0.01%
398
+169
+74% +$1.38K
RXDX
1156
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$4K ﹤0.01%
146
+32
+28% +$927
ACRS icon
1157
Aclaris Therapeutics
ACRS
$743M
$3K ﹤0.01%
248
+69
+39% +$967
ALEC icon
1158
Alector
ALEC
$167M
$3K ﹤0.01%
277
ASPN icon
1159
PUT
Aspen Aerogels
ASPN
$366M
$3K ﹤0.01%
+250
New +$5.04K
DAWN
1160
DELISTED
Day One Biopharmaceuticals
DAWN
$3K ﹤0.01%
181
DBC icon
1161
Invesco DB Commodity Index Tracking Fund
DBC
$1.65B
$3K ﹤0.01%
100
ENTA icon
1162
Enanta Pharmaceuticals
ENTA
$367M
$3K ﹤0.01%
69
KYNB
1163
Kyntra Bio
KYNB
$29M
$3K ﹤0.01%
13
FSLY icon
1164
CALL
Fastly Inc
FSLY
$3.28B
$3K ﹤0.01%
+100
New +$1.41K
LKFT
1165
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.84B
$3K ﹤0.01%
51
+19
+59% +$1.13K
KYMR icon
1166
Kymera Therapeutics
KYMR
$8.79B
$3K ﹤0.01%
150
MNKD icon
1167
MannKind Corp
MNKD
$1.22B
$3K ﹤0.01%
855
MRUS
1168
DELISTED
Merus
MRUS
$3K ﹤0.01%
125
PACB icon
1169
Pacific Biosciences
PACB
$429M
$3K ﹤0.01%
682
QURE icon
1170
uniQure
QURE
$2.52B
$3K ﹤0.01%
158
RCKT icon
1171
Rocket Pharmaceuticals
RCKT
$346M
$3K ﹤0.01%
218
REPL icon
1172
Replimune Group
REPL
$528M
$3K ﹤0.01%
160
SIGA icon
1173
SIGA Technologies
SIGA
$219M
$3K ﹤0.01%
270
+98
+57% +$883
SNDX icon
1174
Syndax Pharmaceuticals
SNDX
$1.73B
$3K ﹤0.01%
167
RVNC
1175
DELISTED
Revance Therapeutics, Inc.
RVNC
$3K ﹤0.01%
246

Similar funds

Daiwa Securities Group's Q2 2022 Portfolio in Review

As of Q2 2022, Daiwa Securities Group held 1,479 positions worth $13.1B, down 18% from $16B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Daiwa Securities Group's Q2 2022 filing shows 56 new, 646 increased, 399 reduced and 58 closed positions. Its largest new stake was HDFC Bank: 143,030 shares worth $3.93M. The largest sale was American Tower, an estimated $263M.

By sector, the portfolio is most concentrated in Real Estate at 61% of assets, up from 60% a quarter earlier, followed by Technology and Healthcare.

  • Daiwa Securities Group's largest Q2 2022 buy was HDFC Bank: 143,030 shares worth $3.93M.
  • Daiwa Securities Group added most to Mid-America Apartment Communities in Q2 2022, an estimated $174M increase.
  • Daiwa Securities Group's biggest Q2 2022 reduction was American Tower, cutting an estimated $263M.
  • Daiwa Securities Group fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $7.68M.
  • Daiwa Securities Group's ten largest holdings make up 38% of its $13.1B portfolio in Q2 2022.
  • Daiwa Securities Group opened 56 new positions and closed 58 in Q2 2022.
  • Daiwa Securities Group's portfolio value fell 18% quarter-over-quarter to $13.1B.

Based on Daiwa Securities Group's 13F filing for Q2 2022, filed 9 Aug 2022.